Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19691441 | 0.90 | MAPT (0.45) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL13431266 | 0.87 | MAPT (0.43) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL20006396 | 0.86 | MAPT (0.47) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL13583844 | 0.86 | L3MBTL1 (0.49) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL22722488 | 0.86 | L3MBTL1 (0.43) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL15828756 | 0.86 | MAPT (0.45) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL12799434 | 0.85 | HTT (0.56) | MAPTL3MBTL1PKMGAARAB9A | |
| SCHEMBL4416245 | 0.85 | CA1 (0.43) | MAPTL3MBTL1PPARAPKMGAA | |
| SCHEMBL23515999 | 0.84 | PKM (0.62) | L3MBTL1PKMALDH1A1HTTPOLB | |
| SCHEMBL13706551 | 0.84 | RARB (0.44) | MAPTL3MBTL1PPARAPKMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851254-B2 | Photoinitiators and curable compositions | AGFA NV (BE) | 2020-12-01 | — | — | US | disclosed |
| US-9314746-B2 | Hydrophilic porous substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-04-19 | — | — | US | disclosed |
| US-8846203-B2 | Method of making ligand functionalized substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140087445-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-03-27 | — | — | US | disclosed |
| US-20130118975-A1 | HYDROPHILIC POROUS SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10851254-B2 | Photoinitiators and curable compositions | FLOT1, VIM, FLNA | MAPT 86/4885L3MBTL1 133/4885PPARA 3579/4885 |
| US-20140087445-A1 | METHOD OF MAKING LIGAND FUNCTIONALIZED SUBSTRATES | SPR, SELPLG, SIGLEC7 | MAPT 4419/4885L3MBTL1 2708/4885PPARA 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.